candoxatril has been researched along with endothelin-1 in 2 studies
| Studies (candoxatril) | Trials (candoxatril) | Recent Studies (post-2010) (candoxatril) | Studies (endothelin-1) | Trials (endothelin-1) | Recent Studies (post-2010) (endothelin-1) |
|---|---|---|---|---|---|
| 62 | 29 | 5 | 12,740 | 632 | 3,394 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hercule, H; Newaz, MA; Oyekan, A; Truong, L; Yousefipour, Z | 1 |
| Newaz, M; Oyekan, A; Yousefipour, Z | 1 |
2 other study(ies) available for candoxatril and endothelin-1
| Article | Year |
|---|---|
Chronic endopeptidase inhibition in DOCA-salt hypertension: mechanism of cardiovascular protection.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Endothelin-1; Hypertension; Indans; Kidney; Male; Models, Animal; Neprilysin; Nitric Oxide; Propionates; Rats; Rats, Sprague-Dawley; Sodium | 2003 |
Natriuretic and renoprotective effect of chronic oral neutral endopeptidase inhibition in acute renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Kidney Injury; Administration, Oral; Angiotensin II; Animals; Antihypertensive Agents; Creatinine; Endothelin-1; Indans; Kidney; Male; Natriuresis; Neprilysin; Nitrates; Propionates; Proteinuria; Rats; Rats, Sprague-Dawley; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 2010 |